Edible products dominant in CBD were associated with greater improvements in pain intensity and sleep quality than were products high in THC
Archives: News Releases
Since 1992, every Thursday and when breaking news warrants, NORML | The NORML Foundation have been issuing weekly press releases for marijuana law supporters and the media.
NORML’s News Releases archives goes back to 1996 and serves as a valuable tool to alert citizens about cannabis-related news and legislation as well as a research tool for reviewing a chronology of marijuana law reform.
The new regulations permit physicians to authorize medical cannabis access to patients diagnosed with irritable bowel syndrome (IBS) and/or obsessive-compulsive disorder.
“Our data show that chronic cannabis use may be associated with … suppression of the neuroinflammatory response following soccer heading,” investigators concluded.
NBA players will no longer be drug tested for cannabis.
Researchers concluded, “Overall, cannabis was effective in relieving anxiety and well-tolerated at the doses consumed, independent of CBD and THC ratios.”
The study’s author identified “no statistically significant impact of cannabis sales on serious injury/fatal crashes” following retail commercialization.
The law limits the ability of the courts to order those on probation, parole, or pre-trial release to refrain from the use of cannabis.
Commission members have called for an independent review of the scoring process and they have indicated that they will not consider any additional applications until the review is completed.
